News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
325,943 Results
Type
Article (15424)
Company Profile (309)
Press Release (310204)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (91437)
Career Advice (283)
Deals (18334)
Drug Delivery (39)
Drug Development (52948)
Employer Resources (33)
FDA (6600)
Job Trends (6259)
News (165708)
Policy (11930)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (969)
Accelerated approval (19)
Adcomms (14)
Allergies (84)
Alliances (25177)
ALS (133)
Alzheimer's disease (1099)
Antibody-drug conjugate (ADC) (245)
Approvals (6811)
Artificial intelligence (274)
Autoimmune disease (118)
Automation (11)
Bankruptcy (163)
Best Places to Work (5523)
BIOSECURE Act (6)
Biosimilars (115)
Biotechnology (237)
Bladder cancer (105)
Brain cancer (49)
Breast cancer (360)
Cancer (3268)
Cardiovascular disease (250)
Career advice (250)
Career pathing (7)
CAR-T (230)
CDC (5)
Celiac Disease (1)
Cell therapy (588)
Cervical cancer (16)
Clinical research (45684)
Collaboration (1203)
Company closure (2)
Compensation (620)
Complete response letters (43)
COVID-19 (1144)
CRISPR (86)
C-suite (585)
Cystic fibrosis (114)
Data (4511)
Denatured (15)
Depression (97)
Diabetes (268)
Diagnostics (1970)
Digital health (15)
Diversity (5)
Diversity, equity & inclusion (10)
Drug discovery (200)
Drug pricing (50)
Drug shortages (3)
Duchenne muscular dystrophy (217)
Earnings (35617)
Editorial (25)
Employer branding (5)
Employer resources (31)
Events (57217)
Executive appointments (678)
FDA (8483)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (1055)
Gene editing (185)
Generative AI (22)
Gene therapy (494)
GLP-1 (518)
Government (1284)
Grass and pollen (3)
Guidances (190)
Healthcare (7754)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (195)
Immuno-oncology (45)
Indications (69)
Infectious disease (1258)
Inflammatory bowel disease (162)
Inflation Reduction Act (10)
Influenza (41)
Intellectual property (175)
Interviews (39)
IPO (10070)
IRA (12)
Job creations (1015)
Job search strategy (215)
JPM (41)
Kidney cancer (9)
Labor market (22)
Layoffs (248)
Leadership (9)
Legal (2114)
Liver cancer (43)
Longevity (11)
Lung cancer (434)
Lymphoma (261)
Machine learning (25)
Management (7)
Manufacturing (397)
MASH (135)
Medical device (4104)
Medtech (4117)
Mergers & acquisitions (9100)
Metabolic disorders (760)
Multiple sclerosis (108)
NASH (13)
Neurodegenerative disease (238)
Neuropsychiatric disorders (70)
Neuroscience (2053)
Neurotech (1)
NextGen: Class of 2026 (2703)
Non-profit (988)
Now hiring (30)
Obesity (344)
Opinion (126)
Ovarian cancer (136)
Pain (116)
Pancreatic cancer (171)
Parkinson's disease (238)
Partnered (15)
Patents (323)
Patient recruitment (348)
Peanut (45)
People (30021)
Pharmaceutical (44)
Pharmacy benefit managers (7)
Phase 1 (16036)
Phase 2 (21183)
Phase 3 (13534)
Pipeline (3478)
Policy (90)
Postmarket research (925)
Preclinical (6708)
Press Release (31)
Prostate cancer (155)
Psychedelics (51)
Radiopharmaceuticals (246)
Rare diseases (668)
Real estate (1859)
Recruiting (13)
Regulatory (11077)
Reports (23)
Research institute (1056)
Resumes & cover letters (32)
Rett syndrome (24)
RNA editing (21)
RSV (22)
Schizophrenia (127)
Series A (190)
Series B (149)
Service/supplier (1)
Sickle cell disease (79)
Special edition (18)
Spinal muscular atrophy (121)
Sponsored (15)
Startups (2242)
State (2)
Stomach cancer (6)
Supply chain (37)
Tariffs (18)
The Weekly (62)
Vaccines (358)
Venture capital (69)
Weight loss (178)
Women's health (29)
Worklife (2)
Date
Today (83)
Last 7 days (367)
Last 30 days (1312)
Last 365 days (19209)
2026 (1889)
2025 (19505)
2024 (22413)
2023 (24765)
2022 (30137)
2021 (31658)
2020 (27260)
2019 (19580)
2018 (14370)
2017 (15950)
2016 (13743)
2015 (16997)
2014 (12273)
2013 (9156)
2012 (9387)
2011 (9254)
2010 (8880)
Location
Africa (164)
Alabama (66)
Alaska (2)
Arizona (110)
Arkansas (5)
Asia (20327)
Australia (3357)
California (7590)
Canada (1928)
China (810)
Colorado (265)
Connecticut (272)
Delaware (244)
Europe (41948)
Florida (1031)
Georgia (229)
Hawaii (2)
Idaho (24)
Illinois (446)
India (37)
Indiana (220)
Iowa (8)
Japan (236)
Kansas (83)
Kentucky (16)
Louisiana (9)
Maine (56)
Maryland (809)
Massachusetts (5875)
Michigan (173)
Minnesota (277)
Mississippi (6)
Missouri (46)
Montana (17)
Nebraska (8)
Nevada (63)
New Hampshire (30)
New Jersey (1814)
New Mexico (14)
New York (1907)
North Carolina (978)
North Dakota (6)
Northern California (3693)
Ohio (201)
Oklahoma (11)
Oregon (26)
Pennsylvania (1404)
Puerto Rico (9)
Rhode Island (26)
South America (259)
South Carolina (16)
Southern California (3024)
Tennessee (71)
Texas (1083)
United States (25609)
Utah (134)
Vermont (1)
Virginia (143)
Washington D.C. (38)
Washington State (625)
West Virginia (2)
Wisconsin (53)
325,943 Results for "galera therapeutics llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
October 23, 2025
·
6 min read
Press Releases
Galera Therapeutics completes acquisition of Nova Pharmaceuticals
December 31, 2024
·
7 min read
Pharm Country
Galera Adopts Limited Duration Stockholder Rights Agreement - May 03, 2024
Galera Therapeutics, Inc. announced that its Board of Directors has unanimously resolved to adopt a limited duration stockholder rights agreement to protect stockholder interests.
May 3, 2024
·
4 min read
Press Releases
Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer
December 17, 2025
·
3 min read
Business
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
Galera Therapeutics, Inc. announced financial results for the fourth quarter and year ended December 31, 2023 and provided recent corporate updates.
March 28, 2024
·
10 min read
Business
Galera Reports First Quarter 2024 Financial Results and Recent Corporate UpdatesCompany’s evaluation of potential strategic alternatives progresses with goal to maximize stockholder value
Galera Therapeutics, Inc. announced financial results for the first quarter ended March 31, 2024, and provided recent corporate updates.
May 13, 2024
·
7 min read
Press Releases
Kathy Spencer-Pike Joins NorthStar Medical Radioisotopes, LLC as Chief Commercial Officer
December 17, 2025
·
3 min read
Press Releases
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
January 16, 2026
·
3 min read
Business
Galera Expands Commercial Leadership Team
Galera Therapeutics, Inc. today announced the appointment of accomplished pharmaceutical sales, market access, and commercial operations executives to Galera’s senior commercial leadership team, effective immediately.
May 1, 2023
·
11 min read
Business
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
Galera Therapeutics, Inc. announced financial results for the third quarter ended September 30, 2023 and provided recent corporate updates.
November 14, 2023
·
11 min read
1 of 32,595
Next
